ClinicalTrials.Veeva

Menu

Excimer Laser Trabeculostomy Glaucoma Treatment Study (ELTGTS)

E

Elios Vision

Status

Active, not recruiting

Conditions

Glaucoma, Primary Open Angle

Treatments

Device: ELIOS Procedure

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG) undergoing cataract surgery

Enrollment

318 patients

Sex

All

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of mild to moderate POAG
  • Operable cataract, eligible for phacoemulsification with a BCVA of 20/40 or worse
  • Medicated IOP of <=24 mmHg
  • Unmedicated diurnal IOP of >=22 mmHg and <=34 mmHg
  • Shaffer angle grade of III or IV
  • CD ratio <=0.8
  • At least 45 years old

Exclusion criteria

  • Closed-angle and secondary glaucomas
  • Prior incisional glaucoma surgery, intraocular surgery, or corneal surgery
  • Cannot undergo medication washout in the study eye
  • Diagnosis of degenerative visual disorders
  • Non-study eye with BCVA worse than 20/80
  • Known corticosteroid responder
  • Pregnant or nursing women; or women of childbearing potential not using medically acceptable birth control

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

318 participants in 1 patient group

ELIOS Procedure
Other group
Description:
ELIOS Procedure
Treatment:
Device: ELIOS Procedure

Trial contacts and locations

20

Loading...

Central trial contact

Rupali Nangia

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems